PFM Health Sciences LP 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | JOUNCE THERAPEUTICS INC. JNCE | PFM Health Sciences LP | 345,926 0.700% | -3,626,942 (-91.29%) | Filing |
| 2022-02-14 12:37 pm Purchase | 2021-12-31 | 13G | JOUNCE THERAPEUTICS INC. JNCE | PFM Health Sciences LP | 3,972,868 7.800% | 1,584,801 (+66.36%) | Filing |